THE HRC TEST
HrC Test, a novel diagnostic tool for distant prediction of cancer, even at asymptomatic early stages, with very high sensitivity.
The diagnostic tool can achieve the following:
The HrC test is a single blood test that can detect all cancers, including solid, haematological and soft tissue sarcomas.
It can detect cancer very early, prior to tumor formation, at pre-stage 1 (stage 0) and stage 1.
The test is highly accurate, with our initial 1000-patient study showing over 99% accuracy.
HrC detects cancer using genetic markers, not at the tumour cell level, but at the seed stage i.e, cancer stem cell level. It tests for the proliferation of cancer cells and hence determines cancer absence or likelihood of presence (from negligible to high).
This critical discovery utilizes peripheral blood and is non-intrusive, unlike tissue biopsies.
Consequently, the detection of cancer at stage zero increases the chances of survival significantly, as well as decreasing the time and cost of treatment.
The test is the first cancer prognostic blood test. In addition to being able to determine that a person does not have cancer, we can also determine the risk that a patient may develop cancer in the next 12 months.
